TY - JOUR AU - Molnar, A. O. AU - Bota, S. E. AU - McArthur, E. AU - Lam, N. N. AU - Garg, A. X. AU - Wald, R. AU - Zimmerman, D. AU - Sood, M. M. PY - 2018 DA - 2018// TI - Risk and complications of venous thromboembolism in dialysis patients JO - Nephrol Dial Transplant VL - 33 UR - https://doi.org/10.1093/ndt/gfy104.FP429 DO - 10.1093/ndt/gfy104.FP429 ID - Molnar2018 ER - TY - JOUR AU - Kearon, C. AU - Akl, E. A. AU - Ornelas, J. AU - Blaivas, A. AU - Jimenez, D. AU - Bounameaux, H. AU - Huisman, M. AU - King, C. S. AU - Morris, T. A. AU - Sood, N. AU - Stevens, S. M. AU - Vintch, J. R. E. AU - Wells, P. AU - Woller, S. C. AU - Moores, L. PY - 2016 DA - 2016// TI - Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report JO - Chest. VL - 149 UR - https://doi.org/10.1016/j.chest.2015.11.026 DO - 10.1016/j.chest.2015.11.026 ID - Kearon2016 ER - TY - JOUR AU - Roy, P. M. AU - Corsi, D. J. AU - Carrier, M. AU - Theogene, A. AU - Wit, C. AU - Dennie, C. AU - Gal, G. AU - Delluc, A. AU - Moumneh, T. AU - Rodger, M. AU - Wells, P. AU - Gandara, E. PY - 2017 DA - 2017// TI - Net clinical benefit of hospitalization versus outpatient management of patients with acute pulmonary embolism JO - J Thromb Haemost VL - 15 UR - https://doi.org/10.1111/jth.13629 DO - 10.1111/jth.13629 ID - Roy2017 ER - TY - STD TI - Jun M, James MT, Manns BJ, Quinn RR, Ravani P, Tonelli M, et al. The association between kidney function and major bleeding in older adults with atrial fibrillation starting warfarin treatment: population based observational study. BMJ. 2015;350:h246. https://doi.org/10.1136/bmj.h246. ID - ref4 ER - TY - JOUR AU - Yang, F. AU - Hellyer, J. A. AU - Than, C. AU - Ullal, A. J. AU - Kaiser, D. W. AU - Heidenreich, P. A. AU - Hoang, D. D. AU - Winkelmayer, W. C. AU - Schmitt, S. AU - Frayne, S. M. AU - Phibbs, C. S. AU - Turakhia, M. P. PY - 2017 DA - 2017// TI - Warfarin utilisation and anticoagulation control in patients with atrial fibrillation and chronic kidney disease JO - Heart. VL - 103 UR - https://doi.org/10.1136/heartjnl-2016-309266 DO - 10.1136/heartjnl-2016-309266 ID - Yang2017 ER - TY - JOUR AU - Nigwekar, S. U. AU - Thadhani, R. AU - Brandenburg, V. M. PY - 2018 DA - 2018// TI - Calciphylaxis JO - N Engl J Med VL - 378 UR - https://doi.org/10.1056/NEJMra1505292 DO - 10.1056/NEJMra1505292 ID - Nigwekar2018 ER - TY - JOUR AU - Garcia, D. A. AU - Baglin, T. P. AU - Weitz, J. I. AU - Samama, M. M. PY - 2012 DA - 2012// TI - Parenteral anticoagulants - antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines JO - Chest. VL - 141 UR - https://doi.org/10.1378/chest.11-2291 DO - 10.1378/chest.11-2291 ID - Garcia2012 ER - TY - JOUR AU - Mavrakanas, T. A. AU - Samer, C. F. AU - Nessim, S. J. AU - Frisch, G. AU - Lipman, M. L. PY - 2017 DA - 2017// TI - Apixaban pharmacokinetics at steady state in hemodialysis patients JO - J Am Soc Nephrol VL - 28 UR - https://doi.org/10.1681/ASN.2016090980 DO - 10.1681/ASN.2016090980 ID - Mavrakanas2017 ER - TY - JOUR AU - Vriese, A. S. AU - Caluwé, R. AU - Bailleul, E. AU - Bacquer, D. AU - Borrey, D. AU - Vlem, B. AU - Vandecasteele, S. J. AU - Emmerechts, J. PY - 2015 DA - 2015// TI - Dose-finding study of rivaroxaban in hemodialysis patients JO - Am J Kidney Dis VL - 66 UR - https://doi.org/10.1053/j.ajkd.2015.01.022 DO - 10.1053/j.ajkd.2015.01.022 ID - Vriese2015 ER - TY - JOUR AU - Dias, C. AU - Moore, K. T. AU - Murphy, J. AU - Ariyawansa, J. AU - Smith, W. AU - Mills, R. M. AU - Weir, M. R. PY - 2016 DA - 2016// TI - Pharmacokinetics, pharmacodynamics, and safety of single-dose rivaroxaban in chronic hemodialysis JO - Am J Nephrol VL - 43 UR - https://doi.org/10.1159/000445328 DO - 10.1159/000445328 ID - Dias2016 ER - TY - JOUR AU - Parasrampuria, D. A. AU - Marbury, T. AU - Matsushima, N. AU - Chen, S. AU - Wickremasingha, P. K. AU - He, L. AU - Dishy, V. AU - Brown, K. S. PY - 2015 DA - 2015// TI - Pharmacokinetics, safety, and tolerability of edoxaban in end-stage renal disease subjects undergoing haemodialysis JO - Thromb Haemost VL - 113 UR - https://doi.org/10.1160/TH14-06-0547 DO - 10.1160/TH14-06-0547 ID - Parasrampuria2015 ER - TY - JOUR AU - Wang, X. AU - Tirucherai, G. AU - Marbury, T. C. AU - Wang, J. AU - Chang, M. AU - Zhang, D. AU - Song, Y. AU - Pursley, J. AU - Boyd, R. A. AU - Frost, C. PY - 2016 DA - 2016// TI - Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end-stage renal disease on hemodialysis JO - J Clin Pharmacol VL - 56 UR - https://doi.org/10.1002/jcph.628 DO - 10.1002/jcph.628 ID - Wang2016 ER - TY - JOUR AU - Chang, M. AU - Yu, Z. AU - Shenker, A. AU - Wang, J. AU - Pursley, J. AU - Byon, W. AU - Boyd, R. A. AU - LaCreta, F. AU - Frost, C. E. PY - 2016 DA - 2016// TI - Effect of renal impairment on the pharmacokinetics, pharmacodynamics, and safety of apixaban JO - J Clin Pharmacol VL - 56 UR - https://doi.org/10.1002/jcph.633 DO - 10.1002/jcph.633 ID - Chang2016 ER - TY - JOUR AU - Wilson, J. A. S. AU - Goralski, K. B. AU - Soroka, S. D. AU - Morrison, M. AU - Mossop, P. AU - Sleno, L. AU - Wang, Y. AU - Anderson, D. R. PY - 2014 DA - 2014// TI - An evaluation of oral dabigatran etexilate pharmacokinetics and pharmacodynamics in hemodialysis JO - J Clin Pharmacol VL - 54 UR - https://doi.org/10.1002/jcph.335 DO - 10.1002/jcph.335 ID - Wilson2014 ER - TY - JOUR AU - Samuelson, B. T. AU - Cuker, A. PY - 2017 DA - 2017// TI - Measurement and reversal of the direct oral anticoagulants JO - Blood Rev VL - 31 UR - https://doi.org/10.1016/j.blre.2016.08.006 DO - 10.1016/j.blre.2016.08.006 ID - Samuelson2017 ER - TY - JOUR AU - January, C. T. AU - Wann, L. S. AU - Calkins, H. AU - Chen, L. Y. AU - Cigarroa, J. E. AU - Cleveland, J. C. AU - Ellinor, P. T. AU - Ezekowitz, M. D. AU - Field, M. E. AU - Furie, K. L. AU - Heidenreich, P. A. AU - Murray, K. T. AU - Shea, J. B. AU - Tracy, C. M. AU - Yancy, C. W. PY - 2019 DA - 2019// TI - 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines and the Heart Rhythm Society JO - J Am Coll Cardiol VL - 74 UR - https://doi.org/10.1016/j.jacc.2019.01.011 DO - 10.1016/j.jacc.2019.01.011 ID - January2019 ER - TY - STD TI - Canada Co. ELIQUIS® (apixaban tablets) Product Monograph. Montreal: Pfizer Canada Inc., Bristol-Myers Squibb; 2019. ID - ref17 ER - TY - JOUR AU - Obialo, C. I. AU - Hunt, W. C. AU - Bashir, K. AU - Zager, P. G. PY - 2012 DA - 2012// TI - Relationship of missed and shortened hemodialysis treatments to hospitalization and mortality: observations from a US dialysis network JO - Clin Kidney J VL - 5 UR - https://doi.org/10.1093/ckj/sfs071 DO - 10.1093/ckj/sfs071 ID - Obialo2012 ER - TY - JOUR AU - Tsapatsaris, N. P. PY - 1991 DA - 1991// TI - Low-dose heparin. A cause of hematoma of rectus abdominis JO - Arch Intern Med VL - 151 UR - https://doi.org/10.1001/archinte.1991.00400030127024 DO - 10.1001/archinte.1991.00400030127024 ID - Tsapatsaris1991 ER - TY - JOUR AU - Siontis, K. C. AU - Zhang, X. AU - Eckard, A. AU - Bhave, N. AU - Schaubel, D. E. AU - He, K. AU - Tilea, A. AU - Stack, A. G. AU - Balkrishnan, R. AU - Yao, X. AU - Noseworthy, P. A. AU - Shah, N. D. AU - Saran, R. AU - Nallamothu, B. K. PY - 2018 DA - 2018// TI - Outcomes associated with apixaban use in patients with end-stage kidney disease and atrial fibrillation in the United States JO - Circulation. VL - 138 UR - https://doi.org/10.1161/CIRCULATIONAHA.118.035418 DO - 10.1161/CIRCULATIONAHA.118.035418 ID - Siontis2018 ER - TY - JOUR AU - Kuno, T. AU - Takagi, H. AU - Ando, T. AU - Sugiyama, T. AU - Miyashita, S. AU - Valentin, N. AU - Shimada, Y. J. AU - Kodaira, M. AU - Numasawa, Y. AU - Briasoulis, A. AU - Burger, A. AU - Bangalore, S. PY - 2020 DA - 2020// TI - Oral anticoagulation for patients with atrial fibrillation on long-term Hemodialysis JO - J Am Coll Cardiol VL - 75 UR - https://doi.org/10.1016/j.jacc.2019.10.059 DO - 10.1016/j.jacc.2019.10.059 ID - Kuno2020 ER - TY - JOUR AU - Königsbrügge, O. AU - Ay, C. PY - 2019 DA - 2019// TI - Atrial fibrillation in patients with end-stage renal disease on hemodialysis: magnitude of the problem and new approach to oral anticoagulation JO - Res Pract Thromb Haemost. VL - 3 UR - https://doi.org/10.1002/rth2.12250 DO - 10.1002/rth2.12250 ID - Königsbrügge2019 ER - TY - JOUR AU - Reed, D. AU - Palkimas, S. AU - Hockman, R. AU - Abraham, S. AU - Le, T. AU - Maitland, H. PY - 2018 DA - 2018// TI - Safety and effectiveness of apixaban compared to warfarin in dialysis patients JO - Res Pract Thromb Haemost VL - 2 UR - https://doi.org/10.1002/rth2.12083 DO - 10.1002/rth2.12083 ID - Reed2018 ER - TY - JOUR AU - Steuber, T. D. AU - Shiltz, D. L. AU - Cairns, A. C. AU - Ding, Q. AU - Binger, K. J. AU - Courtney, J. R. PY - 2017 DA - 2017// TI - A Multicenter analysis of factors associated with Apixaban-related bleeding in hospitalized patients with end-stage renal disease on Hemodialysis JO - Ann Pharmacother VL - 51 UR - https://doi.org/10.1177/1060028017717282 DO - 10.1177/1060028017717282 ID - Steuber2017 ER - TY - JOUR AU - Sarratt, S. C. AU - Nesbit, R. AU - Moye, R. PY - 2017 DA - 2017// TI - Safety outcomes of Apixaban compared with warfarin in patients with end-stage renal disease JO - Ann Pharmacother VL - 51 UR - https://doi.org/10.1177/1060028017694654 DO - 10.1177/1060028017694654 ID - Sarratt2017 ER - TY - JOUR AU - Schafer, J. H. AU - Casey, A. L. AU - Dupre, K. A. AU - Staubes, B. A. PY - 2018 DA - 2018// TI - Safety and efficacy of Apixaban versus warfarin in patients with advanced chronic kidney disease JO - Ann Pharmacother VL - 52 UR - https://doi.org/10.1177/1060028018781853 DO - 10.1177/1060028018781853 ID - Schafer2018 ER - TY - JOUR AU - Stanton, B. E. AU - Barasch, N. S. AU - Tellor, K. B. PY - 2017 DA - 2017// TI - Comparison of the safety and effectiveness of Apixaban versus warfarin in patients with severe renal impairment JO - Pharmacotherapy. VL - 37 UR - https://doi.org/10.1002/phar.1905 DO - 10.1002/phar.1905 ID - Stanton2017 ER - TY - JOUR AU - Garza-Mayers, A. C. AU - Shah, R. AU - Sykes, D. B. AU - Nigwekar, S. U. AU - Kroshinsky, D. PY - 2018 DA - 2018// TI - The successful use of apixaban in dialysis patients with calciphylaxis who require anticoagulation: a retrospective analysis JO - Am J Nephrol VL - 48 UR - https://doi.org/10.1159/000491881 DO - 10.1159/000491881 ID - Garza-Mayers2018 ER - TY - JOUR AU - King, B. J. AU - El-Azhary, R. A. AU - MT, M. E. AU - Shields, R. C. AU - RD, M. B. AU - JT, M. C. AU - MDP, D. PY - 2017 DA - 2017// TI - Direct oral anticoagulant medications in calciphylaxis JO - Int J Dermatol VL - 56 UR - https://doi.org/10.1111/ijd.13685 DO - 10.1111/ijd.13685 ID - King2017 ER - TY - JOUR AU - Kufel, W. D. AU - Zayac, A. S. AU - Lehmann, D. F. AU - Miller, C. D. PY - 2016 DA - 2016// TI - Clinical application and Pharmacodynamic monitoring of Apixaban in a patient with end-stage renal disease requiring chronic Hemodialysis JO - Pharmacotherapy VL - 36 UR - https://doi.org/10.1002/phar.1836 DO - 10.1002/phar.1836 ID - Kufel2016 ER -